Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Breast cancer

Real-World Evidence of Trastuzumab, Pertuzumab, and Docetaxel Combination as a First-Line Treatment for Korean Patients with HER2-Positive Metastatic Breast Cancer

Yong-Pyo Lee, Min-Sang Lee, HongSik Kim, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park

Cancer Res Treat. 2022;54(4):1130-1137. Published online January 17, 2022 DOI: https://doi.org/10.4143/crt.2021.1103

Cited By 1

Real World Evidence of Neoadjuvant Docetaxel/Carboplatin/Trastuzumab/Pertuzumab (TCHP) in Patients with HER2-Positive Early or Locally Advanced Breast Cancer: A Single-Institutional Clinical Experience

Ji-Yeon Kim, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Byung Joo Chae, Se Kyung Lee, Jai Min Ryu, Jin Seok Ahn, Young-Hyuck Im, Seok Won Kim, Yeon Hee Park

Cancer Res Treat. 2022;54(4):1091-1098. Published online January 10, 2022 DOI: https://doi.org/10.4143/crt.2021.901

Cited By 5

Fear of Cancer Recurrence and Its Negative Impact on Health-Related Quality of Life in Long-term Breast Cancer Survivors

Thi Xuan Mai Tran, So-Youn Jung, Eun-Gyeong Lee, Heeyoun Cho, Na Yeon Kim, Sungkeun Shim, Ho Young Kim, Danbee Kang, Juhee Cho, Eunsook Lee, Yoon Jung Chang, Hyunsoon Cho

Cancer Res Treat. 2022;54(4):1065-1073. Published online December 8, 2021 DOI: https://doi.org/10.4143/crt.2021.835

Cited By 8

Clinicopathological Characterization of Double Heterozygosity for BRCA1 and BRCA2 Variants in Korean Breast Cancer Patients

Yoon Ju Bang, Won Kyung Kwon, Seok Jin Nam, Seok Won Kim, Byung-Joo Chae, Se Kyung Lee, Jai Min Ryu, Jong-Won Kim, Jonghan Yu, Jeong Eon Lee

Cancer Res Treat. 2022;54(3):827-833. Published online October 13, 2021 DOI: https://doi.org/10.4143/crt.2021.791

Cited By 1

Effect of Postoperative Radiotherapy after Primary Tumor Resection in De Novo Stage IV Breast Cancer: A Multicenter Retrospective Study (KROG 19-02)

Yeon Joo Kim, Yeon-Joo Kim, Yong Bae Kim, Ik Jae Lee, Jeanny Kwon, Kyubo Kim, Jihye Cha, Myungsoo Kim, In Young Jo, Jung Hoon Kim, Jaehyeon Park, Jin Hee Kim, Juree Kim, Kyung Hwan Shin, Su Ssan Kim

Cancer Res Treat. 2022;54(2):478-487. Published online July 12, 2021 DOI: https://doi.org/10.4143/crt.2021.632

Cited By 3

β1,4-Galactosyltransferase V Modulates Breast Cancer Stem Cells through Wnt/β-catenin Signaling Pathway

Wei Tang, Meng Li, Xin Qi, Jing Li

Cancer Res Treat. 2020;52(4):1084-1102. Published online May 27, 2020 DOI: https://doi.org/10.4143/crt.2020.093

Cited By 7

Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

Ying Lin, Mingxi Lin, Jian Zhang, Biyun Wang, Zhonghua Tao, Yiqun Du, Sheng Zhang, Jun Cao, Leiping Wang, Xichun Hu

Cancer Res Treat. 2020;52(4):1059-1066. Published online April 24, 2020 DOI: https://doi.org/10.4143/crt.2019.633

Cited By 14

RON and MET Co-overexpression Are Significant Pathological Characteristics of Poor Survival and Therapeutic Targets of Tyrosine Kinase Inhibitors in Triple-Negative Breast Cancer

Tian-Hao Weng, Min-Ya Yao, Xiang-Ming Xu, Chen-Yu Hu, Shu-Hao Yao, Yi-Zhi Liu, Zhi-Gang Wu, Tao-Ming Tang, Pei-Fen Fu, Ming-Hai Wang, Hang-Ping Yao

Cancer Res Treat. 2020;52(3):973-986. Published online April 22, 2020 DOI: https://doi.org/10.4143/crt.2019.726

Cited By 11

Detection of Germline Mutations in Breast Cancer Patients with Clinical Features of Hereditary Cancer Syndrome Using a Multi-Gene Panel Test

Hee-Chul Shin, Han-Byoel Lee, Tae-Kyung Yoo, Eun-Shin Lee, Ryong Nam Kim, Boyoung Park, Kyong-Ah Yoon, Charny Park, Eun Sook Lee, Hyeong-Gon Moon, Dong-Young Noh, Sun-Young Kong, Wonshik Han

Cancer Res Treat. 2020;52(3):697-713. Published online February 4, 2020 DOI: https://doi.org/10.4143/crt.2019.559

Cited By 21

PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane–Based Neoadjuvant Chemotherapy

Sanxing Guo, Sibylle Loibl, Gunter von Minckwitz, Silvia Darb-Esfahani, Bianca Lederer, Carsten Denkert

Cancer Res Treat. 2020;52(3):689-696. Published online February 4, 2020 DOI: https://doi.org/10.4143/crt.2019.497

Cited By 20

Prevalence of PALB2 Germline Mutations in Early-onset and Familial Breast/Ovarian Cancer Patients from Pakistan

Muhammad Usman Rashid, Faiz Ali Khan, Noor Muhammad, Asif Loya, Ute Hamann

Cancer Res Treat. 2019;51(3):992-1000. Published online October 11, 2018 DOI: https://doi.org/10.4143/crt.2018.356

Cited By 7

Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers

Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee

Cancer Res Treat. 2019;51(1):280-288. Published online May 4, 2018 DOI: https://doi.org/10.4143/crt.2018.079

Cited By 6

Psychosocial Health of Disease-Free Breast Cancer Survivors Compared with Matched Non-cancer Controls

Boyoung Park, Moo Hyun Lee, Sun-Young Kong, Eun Sook Lee

Cancer Res Treat. 2019;51(1):178-186. Published online April 5, 2018 DOI: https://doi.org/10.4143/crt.2017.585

Cited By 4

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01)

In Hae Park, Seock-Ah Im, Kyung Hae Jung, Joo Hyuk Sohn, Yeon Hee Park, Keun Seok Lee, Sung Hoon Sim, Kyong-Hwa Park, Jee Hyun Kim, Byung Ho Nam, Hee-Jun Kim, Tae-Yong Kim, Kyung-Hun Lee, Sung-Bae Kim, Jin-Hee Ahn, Suee Lee, Jungsil Ro

Cancer Res Treat. 2019;51(1):43-52. Published online February 14, 2018 DOI: https://doi.org/10.4143/crt.2017.562

Cited By 30

Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer

Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves

Cancer Res Treat. 2018;50(4):1226-1237. Published online December 28, 2017 DOI: https://doi.org/10.4143/crt.2017.446

Cited By 6

Evaluation of the Benefit of Radiotherapy in Patients with Occult Breast Cancer: A Population-Based Analysis of the SEER Database

Byoung Hyuck Kim, Jeanny Kwon, Kyubo Kim

Cancer Res Treat. 2018;50(2):551-561. Published online June 1, 2017 DOI: https://doi.org/10.4143/crt.2017.189

Cited By 9

Clinically Significant Unclassified Variants in BRCA1 and BRCA2 Genes among Korean Breast Cancer Patients

Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee

Cancer Res Treat. 2017;49(3):627-634. Published online September 13, 2016 DOI: https://doi.org/10.4143/crt.2016.292

Cited By 10

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

In Hae Park, Joo Hyuk Sohn, Sung Bae Kim, Keun Seok Lee, Joo Seop Chung, Soo Hyeon Lee, Tae You Kim, Kyung Hae Jung, Eun Kyung Cho, Yang Soo Kim, Hong Suk Song, Jae Hong Seo, Hun Mo Ryoo, Sun Ah Lee, So Young Yoon, Chul Soo Kim, Yong Tai Kim, Si Young Kim, Mi Ryung Jin, Jungsil Ro

Cancer Res Treat. 2017;49(3):569-577. Published online September 12, 2016 DOI: https://doi.org/10.4143/crt.2016.289

Cited By 55

Efficacy of Letrozole as First-Line Treatment of Postmenopausal Women with Hormone Receptor–Positive Metastatic Breast Cancer in Korea

Seung Hoon Beom, Jisu Oh, Tae-Yong Kim, Kyung-Hun Lee, Yaewon Yang, Koung Jin Suh, Hyeong-Gon Moon, Sae-Won Han, Do-Youn Oh, Wonshik Han, Tae-You Kim, Dong-Young Noh, Seock-Ah Im

Cancer Res Treat. 2017;49(2):454-463. Published online August 23, 2016 DOI: https://doi.org/10.4143/crt.2016.259

Cited By 1

Improving Conventional or Low Dose Metronomic Chemotherapy with Targeted Antiangiogenic Drugs

Robert S. Kerbel

Cancer Res Treat. 2007;39(4):150-159. Published online December 31, 2007 DOI: https://doi.org/10.4143/crt.2007.39.4.150

Cited By 37

A Locally Advanced Breast Cancer with Difficult Differential Diagnosis of Carcinosarcoma and Atypical Medullary Carcinoma, which had Poor Response to Adriamycin- and Taxane-based Neoadjuvant Chemotherapy: A Case Report

Se Hyun Kim, Hyun Cheol Chung, Jaeheon Jeong, Ji Hoon Kim, Sun Young Rha, Joong Bae Ahn, Nam Hoon Cho, Hei-Cheul Jeung

Cancer Res Treat. 2007;39(3):134-137. Published online September 30, 2007 DOI: https://doi.org/10.4143/crt.2007.39.3.134

Cited By 3

Effects of the Expression of Leptin and Leptin Receptor (OBR) on the Prognosis of Early-stage Breast Cancers

Yongnam Kim, Si-Young Kim, Jae Jin Lee, Jeongho Seo, Youn-Wha Kim, Suck Hwan Koh, Hwi-Joong Yoon, Kyung Sam Cho

Cancer Res Treat. 2006;38(3):126-132. Published online June 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.3.126

Cited By 11

Serum HER2 as a Response Indicator to Various Chemotherapeutic Agents in Tissue HER2 Positive Metastatic Breast Cancer

Sun-Young Kong, Do Hoon Lee, Eun Sook Lee, Susan Park, Keun Seok Lee, Jungsil Ro

Cancer Res Treat. 2006;38(1):35-39. Published online February 28, 2006 DOI: https://doi.org/10.4143/crt.2006.38.1.35

Cited By 11

Expression of Cyclooxygenase-2 in Human Breast Cancer: Relationship with HER-2/neu and other Clinicopathological Prognostic Factors

Eunmi Nam, Soon Nam Lee, Seock-Ah Im, Do-Yeun Kim, Kyoung Eun Lee, Sun Hee Sung

Cancer Res Treat. 2005;37(3):165-170. Published online June 30, 2005 DOI: https://doi.org/10.4143/crt.2005.37.3.165

Cited By 5

The Differential Gene Expression Profiles between Sensitive and Resistant Breast Cancer Cells to Adriamycin by cDNA Microarray

Myung-Ju Ahn, Ki-Hwan Lee, Joon-Ik Ahn, Dong-Hyun Yu, Hye-Sook Lee, Jung-Hye Choi, Joung Soon Jang, Jong Min Bae, Yong-Sung Lee

Cancer Res Treat. 2004;36(1):43-49. Published online February 29, 2004 DOI: https://doi.org/10.4143/crt.2004.36.1.43

Cited By 8

Korean Breast Cancer Data of 1997

J Korean Cancer Assoc. 1999;31(6):1202-1209.

Prognostic Significance of Occult Lymph Node Metastases in Breast Cancer

Won Cheol Park, Kyoung Keun Lee, Kwong Man Lee, Ki Jung Yun

J Korean Cancer Assoc. 1999;31(6):1195-1201.

The Predictors of Axillary Node Metastasis in 2 cm or Less Breast Cancer

Han Sung Kang, Dong Young Noh, Oh Joong Kwon, Yeo Kyu Youn, Seung Keun Oh, Kuk Jin Choe

J Korean Cancer Assoc. 1999;31(6):1188-1194.

Effect of Adjuvant Chemotherapy of Operable Breast Cancer : Survival and Prognostic Factor Analysis

Jeong Gyun Kim, Tae Won Kim, Je Hwan Lee, Sung Bae Kim, Cheolwon Suh, Kyoo Hyung Lee, Jung Shin Lee, Sei Hyun Ahn, Hyesook Chang, Sang Hee Kim, Woo Kun Kim

J Korean Cancer Assoc. 1999;31(5):1018-1026.

Study on the Apoptosis in Human Prostate and Breast Cancer Cells

Eun Jeong Kwon, Myung Sun Lee

J Korean Cancer Assoc. 1999;31(4):728-738.